2024-01-01 2024-12-31 false No description of principal activity Capium Accounts Production 1.1 13779196 2024-01-01 2024-12-31 13779196 bus:FullAccounts 2024-01-01 2024-12-31 13779196 bus:Micro-entities 2024-01-01 2024-12-31 13779196 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 13779196 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 13779196 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13779196 2024-01-01 2024-12-31 13779196 2024-12-31 13779196 bus:RegisteredOffice 2024-01-01 2024-12-31 13779196 core:WithinOneYear 2024-12-31 13779196 core:AfterOneYear 2024-12-31 13779196 1 2024-01-01 2024-12-31 13779196 bus:Director1 2024-01-01 2024-12-31 13779196 bus:Director1 2024-12-31 13779196 bus:Director1 2023-01-01 2023-12-31 13779196 2023-01-01 13779196 2023-01-01 2023-12-31 13779196 2023-12-31 13779196 core:WithinOneYear 2023-12-31 13779196 core:AfterOneYear 2023-12-31 13779196 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 13779196 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 13779196 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 13779196 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 13779196 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 13779196 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 13779196 core:Non-currentFinancialInstruments 2024-12-31 13779196 core:Non-currentFinancialInstruments 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13779196
England and Wales
Unaudited Financial Statements
for the year ended 31 December 2024
for
CAMBRIDGE DERMATOLOGY LTD

Cambridge Dermatology Ltd Contents Page For the year ended 31 December 2024
Balance sheet | 1

Cambridge Dermatology Ltd Balance Sheet As at 31 December 2024
|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | 119,750 |  |  | 30,431 |
Creditors: amount falling due within one year |  | (78,735) |  |  | (27,177) |
Net current assets |  |  | 41,015 |  |  | 3,254
Total assets less current liabilities |  |  | 41,015 |  |  | 3,254
Net assets |  |  | 41,015 |  |  | 3,254
Capital and reserves |  |  | 41,015 |  |  | 3,254
NOTES TO THE ACCOUNTS General Information Cambridge Dermatology Ltd is a private company, limited by shares, registered in England and Wales, registration number 13779196, registration address 8 Union Lane, Chesterton, Cambridge, CB4 1QB. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 2 (2023 : 2).
For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 02 September 2025 and were signed by:
-------------------------------- Anton Alexandroff Director
1